Launch of Apex Laser Series, the World’s First and Only High-Powered Multi-Wavelength Laser for Photobiomodulation

Launch of Apex Laser Series is the newest addition to the premium Aspen Laser family, positioning it ahead of the market as a flagship solution in photobiomodulation (laser therapy) reports Aspen Laser Systems.

The Apex Tri-Wave Laser model is the world’s first and only therapy laser that features three therapeutic wavelengths: 810nm, 980nm and 1064nm, each with the capability of operating at a max power of 15 watts and a combined total output of 45 watts.

With this new product launch, Aspen Laser introduces the 1064nm wavelength to the US market. The 1064nm wavelength is a longer wavelength that can penetrate deeper into tissue. Clinical studies indicate that it has the least dispersion within biological tissues due to its decreased melanin absorption. The result is deep activation of metabolic processes vital for all cellular activities.

The Apex Laser Series allows healthcare practitioners a new and effective clinical tool to deliver optimal outcomes. This new model combines exclusive high average power PowerDose diodes and advanced Wavelength MultiPlexer Technology to provide the broadest range and selections of therapeutic wavelengths. In addition to the Apex Tri-Wave 45 watt model, the Apex Laser Series includes a Dual-Wave Laser model option featuring 60 watts of total output with 30 watts each of 810nm and 1064nm (or 980nm) wavelengths. The Apex Dual-Wave Laser model is also the only one of its kind in the world.

“The Apex Laser Series is surpassing the results that we originally planned for,” said Charles Vorwaller, CEO of Aspen Laser Systems, LLC. “This product has been in research and development for the past two years, and because of the broad range of power, wavelengths and operating mode choices, it is a wonderful support for our Patient Response Driven Clinical Protocols. This means a healthcare professional will have significantly better outcomes and physiological effects that include increased circulation, reduced inflammation, pain reduction and enhanced tissue healing. The Apex Laser Series is a great addition for any healthcare professional, whether experienced or just starting out with photobiomodulation.”

Photobiomodulation is a non-invasive and painless treatment used to treat pain and inflammation from conditions such as arthritis, tendonitis, and acute joint or muscle injuries, and the treatment can be applied to both humans and animals. Instead of just treating symptoms that may provide temporary benefits, photobiomodulation is a superior treatment option because it provides energy to cells that trigger a chemical response resulting in the body to heal itself.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.